Malignant mesothelioma
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Malignant mesothelioma is a fatal asbestos-associated malignancy originating from the lining cells (mesothelium) of the pleural and peritoneal cavities, as well as the pericardium and the tunica vaginalis. The exact prevalence is unknown but it is estimated that mesotheliomas represent less than 1% of all cancers. Its incidence is increasing, with an expected peak in the next 10-20 years. Pleural malignant mesothelioma is the most common form of mesothelioma. Typical presenting features are those of chest pain and dyspnoea. Breathlessness due to a pleural effusion without chest pain is reported in about 30% of patients. A chest wall mass, weight loss, sweating, abdominal pain and ascites (due to peritoneal involvement) are less common presentations. Mesothelioma is directly attributable to occupational asbestos exposure with a history of exposure in over 90% of cases. There is also evidence that mesothelioma may result from both para-occupational exposure and non-occupational "environmental" exposure. Idiopathic or spontaneous mesothelioma can also occur in the absence of any exposure to asbestos, with a spontaneous rate in humans of around one per million. A combination of accurate exposure history, along with examination radiology and pathology are essential to make the diagnosis. Distinguishing malignant from benign pleural disease can be challenging. The most helpful CT findings suggesting malignant pleural disease are 1) a circumferential pleural rind, 2) nodular pleural thickening, 3) pleural thickening of > 1 cm and 4) mediastinal pleural involvement. Involvement of a multidisciplinary team is recommended to ensure prompt and appropriate management, using a framework of radiotherapy, chemotherapy, surgery and symptom palliation with end of life care. Compensation issues must also be considered. Life expectancy in malignant mesothelioma is poor, with a median survival of about one year following diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vogelzang, N. J., Rusthoven, J. J., Symanowski, J., Denham, C., Kaukel, E., Ruffie, P., Gatzemeier, U., Boyer, M., Emri, S., Manegold, C., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.136 · Cited by 3,060
Lung diseases due to environmental exposures to erionite and asbestos in Turkey
Emri, S., Demir, A., Dogan, M., Akay, H., Bozkurt, B., Carbone, M., & Baris, I. (2002) · Toxicology Letters · doi:10.1016/s0378-4274(01)00507-0 · Cited by 98 · cited 2×
“Emri S, Demir A, Dogan M, Akay H, Bozkurt B, Carbone M, Baris I: Lung diseases due to environmental exposures to erionite and asbestos in Turkey.”
BackgroundSakellariou, K., Malamou-Mitsi, V, Haritou, A., Koumpaniou, C., Stachouli, C., Dimoliatis, I., & Constantopoulos, S. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09061206 · Cited by 62 · cited 2×
“Sakellariou K, Malamou-Mitsi V, Haritou A, Koumpaniou C, Stachouli C, Dimoliatis ID, Constantopoulos SH: Malignant pleural mesothelioma from nonoccupational asbestos exposure in Metsovo (north-west Greece): slow end of an epidemic?”
Background
Cited by
Asbestos in High-Risk Communities: Public Health Implications
Emmett, E. A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18041579 · Cited by 33
Berk, S., Yalcin, H., Dogan, O. T., Epozturk, K., Akkurt, I., & Seyfikli, Z. (2014) · Environmental Geochemistry and Health · doi:10.1007/s10653-013-9518-y · Cited by 17
Expression analysis of HMGB 1 in histological samples of malignant pleural mesothelioma
Rrapaj, E., Trisolini, E., Bertero, L., Salvo, M., Indellicato, R., Andorno, S., Garcia‐Manteiga, J. M., Rena, O., & Boldorini, R. L. (2018) · Histopathology · doi:10.1111/his.13470 · Cited by 17
Metadata
- Authors
- Moore, A. J., Parker, R. J., & Wiggins, J.
- Venue
- Orphanet Journal of Rare Diseases
- Published
- 2008-12
- Volume
- 3
- Issue
- 1
- Pages
- 34-34
- ISSN
- 1750-1172 (ISSN-L)
- OpenAlex
- W3188375976
- Cited by
- 136
- References
- 3
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Malignant mesothelioma. https://app.cochat.ai/papers/10.1186/1750-1172-3-34
- The paper
- Moore, A. J., Parker, R. J., & Wiggins, J. (2008). Malignant mesothelioma. Orphanet Journal of Rare Diseases. https://doi.org/10.1186/1750-1172-3-34
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.